Kiminobu Yokoi

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Takahiro Sawada, Hideo Tsubata, Naoko Hashimoto et al. · Cardiovascular Diabetology · 2016 · 101 citations · Full text

Medicine, Cardiology, Endocrinology +17

Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary Lesions

Tetsuya Amano, Tatsuaki Matsubara, Tadayuki Uetani et al. · Journal of the American College of Cardiology · 2007 · 82 citations

Medicine, Cardiology, Clinical Sciences +17

Abnormal Glucose Regulation Is Associated With Lipid-Rich Coronary Plaque

Tetsuya Amano, Tatsuaki Matsubara, Tadayuki Uetani et al. · JACC. Cardiovascular imaging · 2008 · 72 citations

Medicine, Biochemistry, Cardiology +14

Comparison of Tissue Characteristics Between Acute Coronary Syndrome and Stable Angina Pectoris - An Integrated Backscatter Intravascular Ultrasound Analysis of Culprit and Non-Culprit Lesions -

Hirohiko Ando, Tetsuya Amano, Tatsuaki Matsubara et al. · Circulation Journal · 2010 · 47 citations · Full text

Medicine, Cardiology, Clinical Sciences +17